share_log

HC Wainwright & Co. Maintains Buy on AnaptysBio, Lowers Price Target to $52

Benzinga ·  Nov 6 13:45  · Ratings

HC Wainwright & Co. analyst Emily Bodnar maintains AnaptysBio (NASDAQ:ANAB) with a Buy and lowers the price target from $55 to $52.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment